These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15796381)

  • 1. Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study.
    Kikuta K; Takagi Y; Nozaki K; Hanakawa T; Okada T; Mikuni N; Miki Y; Fushmi Y; Yamamoto A; Yamada K; Fukuyama H; Hashimoto N
    J Neurosurg; 2005 Mar; 102(3):470-5. PubMed ID: 15796381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbleeds in moyamoya disease: susceptibility-weighted imaging versus T2*-weighted imaging at 3 Tesla.
    Mori N; Miki Y; Kikuta K; Fushimi Y; Okada T; Urayama S; Sawamoto N; Fukuyama H; Hashimoto N; Togashi K
    Invest Radiol; 2008 Aug; 43(8):574-9. PubMed ID: 18648257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial relationship between cerebral microbleeds, moyamoya vessels, and hematoma in moyamoya disease.
    Kazumata K; Shinbo D; Ito M; Shichinohe H; Kuroda S; Nakayama N; Houkin K
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1421-8. PubMed ID: 24529354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study.
    Jang DK; Huh PW; Lee KS
    J Neurosurg; 2016 Jun; 124(6):1738-45. PubMed ID: 26566210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease.
    Kikuta K; Takagi Y; Nozaki K; Sawamoto N; Fukuyama H; Hashimoto N
    Neurosurgery; 2008 Jan; 62(1):104-11, discussion 111-2. PubMed ID: 18300897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization Surgery in Childhood Associated with a Low Incidence of Microbleeds in Adult Patients with Moyamoya.
    Yamao Y; Takahashi JC; Funaki T; Mineharu Y; Kikuchi T; Okada T; Togashi K; Miyamoto S
    World Neurosurg; 2020 Jan; 133():e716-e721. PubMed ID: 31589987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of asymptomatic cerebral microbleeds in patients with hemorrhagic onset-type moyamoya disease: a phase-sensitive MRI study and meta-analysis.
    Qin Y; Ogawa T; Fujii S; Shinohara Y; Kitao S; Miyoshi F; Takasugi M; Watanabe T; Kaminou T
    Acta Radiol; 2015 Mar; 56(3):329-38. PubMed ID: 24558166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences using 3-tesla magnetic resonance imaging in the treatment of Moyamoya disease.
    Kikuta K
    Acta Neurochir Suppl; 2008; 103():123-6. PubMed ID: 18496957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: a prospective cohort study with 2 years of follow-up.
    Sun W; Yuan C; Liu W; Li Y; Huang Z; Zhu W; Li M; Xu G; Liu X
    Cerebrovasc Dis; 2013; 35(5):469-75. PubMed ID: 23736000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study.
    Nighoghossian N; Hermier M; Adeleine P; Blanc-Lasserre K; Derex L; Honnorat J; Philippeau F; Dugor JF; Froment JC; Trouillas P
    Stroke; 2002 Mar; 33(3):735-42. PubMed ID: 11872897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in hemorrhagic moyamoya disease.
    Wan M; Duan L
    Br J Neurosurg; 2015 Apr; 29(2):189-91. PubMed ID: 25365664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult moyamoya disease in the asymptomatic Japanese population.
    Ikeda K; Iwasaki Y; Kashihara H; Hosozawa K; Anan K; Tamura M; Satoyoshi E; Ikeda H
    J Clin Neurosci; 2006 Apr; 13(3):334-8. PubMed ID: 16540331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of asymptomatic microbleeds in patients with moyamoya disease.
    Ishikawa T; Kuroda S; Nakayama N; Terae S; Kudou K; Iwasaki Y
    Neurol Med Chir (Tokyo); 2005 Oct; 45(10):495-500; discussion 500. PubMed ID: 16247234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, locations, and longitudinal course of silent microbleeds in moyamoya disease: a prospective T2*-weighted MRI study.
    Kuroda S; Kashiwazaki D; Ishikawa T; Nakayama N; Houkin K
    Stroke; 2013 Feb; 44(2):516-8. PubMed ID: 23223508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nascent deep microbleeds and stroke recurrences.
    Imaizumi T; Inamura S; Kohama I; Yoshifuji K; Nomura T; Komatsu K
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):520-8. PubMed ID: 23800499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid appearance of new cerebral microbleeds after acute ischemic stroke.
    Jeon SB; Kwon SU; Cho AH; Yun SC; Kim JS; Kang DW
    Neurology; 2009 Nov; 73(20):1638-44. PubMed ID: 19759365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection.
    Vernooij MW; Ikram MA; Wielopolski PA; Krestin GP; Breteler MM; van der Lugt A
    Radiology; 2008 Jul; 248(1):272-7. PubMed ID: 18490493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical correlating factors and cognitive function in community-dwelling healthy subjects with cerebral microbleeds.
    Takashima Y; Mori T; Hashimoto M; Kinukawa N; Uchino A; Yuzuriha T; Yao H
    J Stroke Cerebrovasc Dis; 2011; 20(2):105-10. PubMed ID: 20580259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.